查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1617848

感染疾病診斷市場：按產品、技術、測試類型、樣本、應用和最終用戶 - 2025-2030 年全球預測

Infectious Disease Diagnostic Market by Product (Instruments, Reagents, Software & Services), Technology (Biochemical Technology, Conventional Technology, Molecular Technology), Testing Type, Sample, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年感染疾病診斷市值為247.6億美元，預計到2024年將達到264.4億美元，複合年成長率為7.29%，到2030年將達到405.3億美元。

感染疾病診斷市場包括快速且準確地識別病原體及其引起的疾病的技術和技術。這一領域至關重要，因為世界上不斷變化的感染疾病挑戰強調需要及時診斷，以促進有效的治療和控制措施。診斷應用於各種環境，從臨床實驗室和醫院到家庭就地檢驗和社區健康計劃，影響公共衛生結果和患者管理策略。最終用戶包括醫療保健提供者、製藥公司、研究機構和政府機構。該市場的成長是由感染疾病發病率增加、分子診斷技術進步、人們對早期發現疾病的必要性的認知不斷增強以及政府對研究計劃的資助等因素推動的。 COVID-19 大流行凸顯了迫切的需求，導致可以同時測試多種病原體的多重診斷技術的激增，並在次世代定序和人工智慧驅動的診斷工具等領域創造了投資機會。然而，市場擴張面臨障礙，例如檢測設備和試劑的高成本、嚴格的監管環境以及在資源匱乏的環境中獲取和應用診斷技術的挑戰。策略建議包括專注於攜帶式和具有成本效益的診斷測試的創新，以應對未服務的市場，以及開發將診斷與更準確和可追蹤的電子健康記錄相結合的數位平台，其中一個例子就是投資。研究和開發還應考慮改進現有技術，以提高敏感性和特異性並擴大診斷能力。為了確保永續成長，建議政府、私營部門和學術界之間建立合作夥伴關係，以加強技術力和可近性。該市場是動態的，其特點是技術快速進步，並且迫切需要針對全球新出現和重新出現的感染疾病的高效且可擴展的解決方案。

主要市場統計
基準年[2023] 247.6億美元
預計年份 [2024] 264.4億美元
預測年份 [2030] 405.3億美元
複合年成長率（%） 7.29%

市場動態：快速發展的感染疾病診斷市場的關鍵市場洞察

供需的動態交互作用正在改變感染疾病診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球感染疾病流行增加且週期性爆發
    • 從集中式實驗室轉向分散式就地檢驗
    • 政府在感染疾病控制和預防方面積極採取的措施和投資
  • 市場限制因素
    • 報銷不足和醫療費用上漲限制了新診斷技術的使用
  • 市場機會
    • 感染疾病診斷試劑套件和解決方案的進展
    • 推出適用於居家照護環境的感染疾病診斷套件
  • 市場挑戰
    • 準確性問題，缺乏熟練的專業人員

波特五力策略工具引領感染疾病診斷市場

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解感染疾病診斷市場的外部影響

外部宏觀環境因素在塑造感染疾病診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解感染疾病診斷市場的競爭狀況

對感染疾病診斷市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣感染疾病診斷市場供應商績效評估

FPNV 定位矩陣是評估感染疾病診斷市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪感染疾病診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對感染疾病診斷市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病的全球盛行率不斷上升和週期性爆發
      • 重點從集中式臨床實驗室轉向分散式臨床實驗室
      • 政府在感染疾病控制和預防方面的支持性努力和投資
    • 抑制因素
      • 報銷不足和醫療費用上漲限制了新診斷技術的使用
    • 機會
      • 感染疾病診斷試劑套件和解決方案的進展
      • 推出居家醫療護理的感染疾病診斷套件
    • 任務
      • 準確性問題和缺乏熟練的專業人員
  • 市場區隔分析
    • 產品：感染疾病診斷分析儀器應用進展
    • 測試類型：更多採用現場護理 (PoC) 測試，以實現便利和緊急應用
    • 應用：增加使用疾病診斷試劑套件診斷病毒感染
    • 最終用戶：感染疾病診斷產品在醫院的普及
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章感染疾病診斷市場：依產品

  • 裝置
  • 試劑
  • 軟體和服務

第7章感染疾病診斷市場：依技術分類

  • 生化技術
  • 常規技術
  • 分子技術

第8章感染疾病診斷市場檢測類型

  • 臨床檢查
  • 概念驗證測試

第9章感染疾病診斷市場樣本

  • 血液、血漿、血清
  • 尿

第10章感染疾病診斷市場：依應用分類

  • 細菌感染
  • 心血管感染疾病
  • 中樞神經系統感染疾病
  • 黴菌感染疾病
  • 性行為感染傳染病
  • 病毒感染

第11章感染疾病診斷市場：依最終用戶分類

  • 診斷實驗室
  • 醫院
  • 調查機構

第12章 北美和南美感染疾病診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太地區感染疾病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲感染疾病診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Medix Biochemica 收購美國ViroStat 以擴大感染疾病抗體供應
    • Oxford Nanopore 與生物梅里埃簽署策略合作夥伴協議，開發創新感染疾病診斷
    • Thermo Fisher Scientific 在印度推出感染疾病檢測的 PCR 試劑套件
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • bioMerieux SA
  • Cardinal Health Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Grifols, SA
  • Hologic Inc.
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Konica Minolta, Inc.
  • Labsystems Diagnostics Oy
  • Merck KGaA
  • Olympus Corporation
  • Perkin Elmer, Inc.
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-4316E4E89510

The Infectious Disease Diagnostic Market was valued at USD 24.76 billion in 2023, expected to reach USD 26.44 billion in 2024, and is projected to grow at a CAGR of 7.29%, to USD 40.53 billion by 2030.

The infectious disease diagnostic market encompasses techniques and technologies used to identify pathogens and the diseases they cause rapidly and accurately. This sector is vital due to the ongoing global challenge of infectious diseases, emphasizing the need for timely diagnosis to facilitate effective treatment and control measures. Diagnostics are applied in various settings, from clinical labs and hospitals to point-of-care testing at home and community health programs, influencing public health outcomes and patient management strategies. End-users range across healthcare providers, pharmaceutical companies, research institutes, and governmental bodies. Growth in this market is propelled by factors such as the increasing incidence of infectious diseases, advancements in molecular diagnostics technologies, heightened awareness about the need for early disease detection, and government funding for research initiatives. The COVID-19 pandemic has spotlighted urgent demands, leading to a surge in multiplex diagnostic technologies that can concurrently test for multiple pathogens, opening opportunities for investment in areas like next-generation sequencing and AI-driven diagnostic tools. However, market expansion faces hurdles such as high costs of testing equipment and reagents, strict regulatory landscapes, and challenges in accessing and applying diagnostic technologies in low-resource settings. Strategic recommendations include focusing on innovations in portable and cost-effective diagnostic tests to serve unserved markets and investing in the development of digital platforms that integrate diagnosis with electronic medical records for better accuracy and tracking. Research and development should also consider refining existing technologies to improve sensitivity and specificity, thereby broadening diagnostic capabilities. To ensure sustainable growth, collaborative partnerships between governments, private sectors, and academia are recommended to enhance both technological capabilities and accessibility. The market is dynamic, characterized by rapid technological advancements and a pressing need for efficient, scalable solutions to globally emerging and re-emerging infectious diseases.

KEY MARKET STATISTICS
Base Year [2023] USD 24.76 billion
Estimated Year [2024] USD 26.44 billion
Forecast Year [2030] USD 40.53 billion
CAGR (%) 7.29%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infectious Disease Diagnostic Market

The Infectious Disease Diagnostic Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing global prevalence and periodic outbreaks of infectious diseases
    • Shift in focus towards decentralized point-of-care testing from centralized laboratories
    • Supportive government initiatives and investments toward infectious disease control and prevention
  • Market Restraints
    • Inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques
  • Market Opportunities
    • Advancements in infectious disease diagnostics kits and solutions
    • Emergence of infectious disease diagnostics kits for homecare settings
  • Market Challenges
    • Accuracy issues and limited availability of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Infectious Disease Diagnostic Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infectious Disease Diagnostic Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infectious Disease Diagnostic Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infectious Disease Diagnostic Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infectious Disease Diagnostic Market

A detailed market share analysis in the Infectious Disease Diagnostic Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infectious Disease Diagnostic Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infectious Disease Diagnostic Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infectious Disease Diagnostic Market

A strategic analysis of the Infectious Disease Diagnostic Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infectious Disease Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Techne Corporation, bioMerieux SA, Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Grifols, S.A., Hologic Inc., Illumina, Inc., Johnson & Johnson Services, Inc., Konica Minolta, Inc., Labsystems Diagnostics Oy, Merck KGaA, Olympus Corporation, Perkin Elmer, Inc., Pfizer Inc., Qiagen N.V., Quest Diagnostics, Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Infectious Disease Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments, Reagents, and Software & Services.
  • Based on Technology, market is studied across Biochemical Technology, Conventional Technology, and Molecular Technology.
  • Based on Testing Type, market is studied across Laboratory Testing and PoC Testing.
  • Based on Sample, market is studied across Blood, Plasma, & Serum and Urine.
  • Based on Application, market is studied across Bacterial Infection, Cardiovascular Infection, CNS Infection, Fungal Infection, Sexually Transmitted Disease, and Viral Infection.
  • Based on End User, market is studied across Diagnostic Laboratories, Hospital, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing global prevalence and periodic outbreaks of infectious diseases
      • 5.1.1.2. Shift in focus towards decentralized point-of-care testing from centralized laboratories
      • 5.1.1.3. Supportive government initiatives and investments toward infectious disease control and prevention
    • 5.1.2. Restraints
      • 5.1.2.1. Inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in infectious disease diagnostics kits and solutions
      • 5.1.3.2. Emergence of infectious disease diagnostics kits for homecare settings
    • 5.1.4. Challenges
      • 5.1.4.1. Accuracy issues and limited availability of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Advancing applications of analytical instruments for infectious disease diagnostics
    • 5.2.2. Testing Type: Emerging adoption of Point-of-Care (PoC) testing for convenience and emergency applications
    • 5.2.3. Application: Increasing use of disease diagnosis kits to diagnose viral infections
    • 5.2.4. End-User: Penetration of infectious disease diagnosis products in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infectious Disease Diagnostic Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents
  • 6.4. Software & Services

7. Infectious Disease Diagnostic Market, by Technology

  • 7.1. Introduction
  • 7.2. Biochemical Technology
  • 7.3. Conventional Technology
  • 7.4. Molecular Technology

8. Infectious Disease Diagnostic Market, by Testing Type

  • 8.1. Introduction
  • 8.2. Laboratory Testing
  • 8.3. PoC Testing

9. Infectious Disease Diagnostic Market, by Sample

  • 9.1. Introduction
  • 9.2. Blood, Plasma, & Serum
  • 9.3. Urine

10. Infectious Disease Diagnostic Market, by Application

  • 10.1. Introduction
  • 10.2. Bacterial Infection
  • 10.3. Cardiovascular Infection
  • 10.4. CNS Infection
  • 10.5. Fungal Infection
  • 10.6. Sexually Transmitted Disease
  • 10.7. Viral Infection

11. Infectious Disease Diagnostic Market, by End User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospital
  • 11.4. Research Institutes

12. Americas Infectious Disease Diagnostic Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Infectious Disease Diagnostic Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Infectious Disease Diagnostic Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering
    • 15.3.2. Oxford Nanopore and bioMerieux to Enter into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics
    • 15.3.3. Thermo Fisher Scientific Launches PCR Kits for Infectious Disease Detection in India
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Adaptive Biotechnologies Corporation
  • 3. Agilent Technologies, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Bio-Techne Corporation
  • 6. bioMerieux SA
  • 7. Cardinal Health Inc.
  • 8. Danaher Corporation
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. GE Healthcare
  • 11. Grifols, S.A.
  • 12. Hologic Inc.
  • 13. Illumina, Inc.
  • 14. Johnson & Johnson Services, Inc.
  • 15. Konica Minolta, Inc.
  • 16. Labsystems Diagnostics Oy
  • 17. Merck KGaA
  • 18. Olympus Corporation
  • 19. Perkin Elmer, Inc.
  • 20. Pfizer Inc.
  • 21. Qiagen N.V.
  • 22. Quest Diagnostics
  • 23. Siemens Healthineers AG
  • 24. Sysmex Corporation
  • 25. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET RESEARCH PROCESS
  • FIGURE 2. INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. INFECTIOUS DISEASE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFECTIOUS DISEASE DIAGNOSTIC MARKET DYNAMICS
  • TABLE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, PLASMA, & SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. INFECTIOUS DISEASE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023